Lexicon Pharma (LXRX) – Analyst Ratings
-
Jefferies Starts Lexicon Pharmaceuticals (LXRX) at Hold, 'Heart Failure Approval is Likely, But Market Uptake Less Clear'
-
UPDATE: Piper Sandler Starts Lexicon Pharmaceuticals (LXRX) at Overweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LXRX Stock Lookup